Overexpression of VEGF165 is associated with poor prognosis of cervical cancer-Reference-Cited by-同舟云学术

Overexpression of VEGF165 is associated with poor prognosis of cervical cancer

Published:2020-09-27 Issue:11 Volume:46 Page:2397-2406
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Patel Kinjal A.¹,Patel Bijal M.²,Thobias Ashi R.¹,Gokani Riddhi A.¹,Chhikara Archana Bharti²,Desai Ava D.²,Patel Prabhudas S.¹

Affiliation:

1. Molecular Oncology Laboratory, Cancer Biology Department The Gujarat Cancer & Research Institute Ahmedabad Gujarat India

2. Department of Gynecological Oncology The Gujarat Cancer & Research Institute Ahmedabad Gujarat India

Funder

Gujarat Cancer Society

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.14483

Reference29 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. State of the science in cervical cancer: Where we are today and where we need to go

3. Expressions of VEGF and miR‐21 in tumor tissues of cervical cancer patients with HPV infection and their relationships with prognosis;Yuan Y;Eur Rev Med Pharmacol Sci,2018

4. Network Topologies Decoding Cervical Cancer

5. Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candidate Genes and Pathways in Cervical Cancer: A Systematic Review and Integrated Bioinformatic Analysis;Cancers;2023-01-30

2. The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy;International Journal of Molecular Sciences;2022-12-09

3. RIPOR2 Expression Decreased by HPV-16 E6 and E7 Oncoproteins: An Opportunity in the Search for Prognostic Biomarkers in Cervical Cancer;Cells;2022-12-06

4. Safety and Efficacy of Treatment with/without Ramucirumab in Advanced or Metastatic Cancer: A Meta-Analysis of 11 Global, Double-Blind, Phase 3 Randomized Controlled Trials;Journal of Oncology;2022-11-21

5. The recent advancements in the early detection of cancer biomarkers by DNAzyme-assisted aptasensors;Journal of Nanobiotechnology;2022-10-04